Professional Documents
Culture Documents
The Initiative
With the script ,following each slide
Medicine Panel
• From the graph below we can that the area of interest is between 1-100 nm ,
which is equvilent to glucose molecule up to size of a viruse
Nanotechnology
History
1959 R.feyman
There's Plenty of Room at the Bottom
1977 Drexler
Building machines on the scale of molecules
Micro
Min
iatu
r iza
tio n
Nano Biology
i t y
le x
m p
c o
la r
ec u
o l
Atomic M
1950 2000 2050
AFM invention
Nanomedicine
Slide 5
• To sum it up Nanotechnology is a size-based
science field which can be summarized as an
umbrella term used to define the products,
processes and properties at the nanoscale
that is of structures less than 100nm (less than
a virus size)
Nanomedicine
The ESF Definition
Analytical tools
Nano Imaging
Zinostatin stimalmer
Polymer SMANCS
Liver disease PEG family
Detoxification Var.
• For more information on the principles on which these drugs are based you
can referred to our last year presentation in which we discussed these
principles in details.
Nanomedicine Roadmap
Action plan
• the coming years hold a huge hope for Africa, we think that start of something big could take place now, specialy that we have
factors that can help us doing so
For example
• Human resource huge diversity with abundant resources, the candidate in Africa is of high potential yet healthcare cost are much
lower than many other countries
• Since african development is on the rise and and the general attitude is towords opening to research , it is belived that this
scientific field would be easy to implement
• It’s widly known that africa carries the largest medical need around the world and already carries the most spending in healthcare
aid origanizations like the WHO, which will also present a huge opertunity to induce a noticable change with minute advances
• Finally egypt has the leading resources and optimum scientific vantages to take the lead since we are already took our first steps
• So to set this in action there is a number of intiaition factors that need to be supplied and some stratgies that need to be followed
,
Slide 10.end
So to set this in action there is a number of
initiation factors that need to be supplied and
some strategies that need to be followed ,
Nanomedicine Roadmap
Initiation
Expertise
●
of Different Experiences as medicine, physics and chemistry
Funding
●
Establishing a stable funding resource
Partnership
●
True Goal oriented partnerships
Scientific training
membrane biophysics
Communication
Computational science
Life sciences
Funding
●
Establishing funding resources
•Public orientation
•Grants
•Investors
•Fund raising projects
Nanomedicine
Slide 14
• The prospect of funding can be seriuos issue in
africa however there are a few angles that can
asssit in this matter such as .
• Increasing public and government awarness and
orintation which will be discussed later.
• Applying for grants , tempting investors to invest in
nanomedicine , and fund raising projects that can
be in the form of the production of commercial
products that can be used to fun a parallel research
Nanomedicine Roadmap
Action plan
Public orientation
Government support
And Informing the public through awareness programs that can help them
understand the difference between the facts that should by supported and fiction that should
be neglected
Nanomedicine
Slide 15
• At any stage of our lab , politicians need to be briefed with the
work of the lab, noting that such field will not only provide better
treatment, D but also there will be many commercial benefits by
decreasing the expenses of treatment and decreasing morbidity,
such brief is essential so we can convince dissen makers to
allocate a budget and funds for research and also to keep all
parties –including the public - oriented with the ongoing research
Partnership
●
Establish a True Goal-oriented partnerships
Exchange experiences
Design experiments and split roles
Nanomedicine
Slide 16
• Establishing true goal oriented partnerships to
exchange experiences and to assist in
experimental design and perhaps partnering
until our facility has enough expertise to
operate on its own, although sharing
experiences and results would still be in effect.
And that’s it !!
Questions please?
Presented by:
Momen Zalabany
Nanomedicine Research Group
Nanomedicine
Slide 17
• And thats all about this presentaion, this was
our visoin of our student group, thank you for
your time and attention ,